Moreover, CCK8 assay and flow cytometry (Additional file 4: Fig. S3b, c) for apoptosis detection of CRC cells showed that the higher concentrations of KRAS (Additional file 4: Fig. S3a) led to larger resistance of cetuximab. The gene discussed is KRAS; the disease is colorectal carcinoma.